Efficacy and Safety of Human Lipoprotein Lipase (LPL)[S447X] Expressed by an Adeno-Associated Viral Vector in LPL-deficient Subjects
Clinical trial NCT00891306 · COMPLETED
Trial details
- NCT number
- NCT00891306
- Sponsor
- Amsterdam Molecular Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2010-08-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.